Teva asks FDA to define Copaxone as biologics drug

Copaxone
Copaxone

The Israeli pharmaceutical company is still investing major efforts to prevent further generic competition for its multiple sclerosis treatment.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is continuing to invest major efforts in protecting its most valuable ever asset - multiple sclerosis treatment Copaxone. Teva has asked the US Food and Drug Administration (FDA) to include Copaxone in the list of biologics drugs that it will issue next month.

Such a move will make it more difficult to make copycat generics of Copaxone, although this will be shutting the stable door after the horse has bolted with some generic rivals of the multiple sclerosis treatment already on the market. Nevertheless, it may hamper approval of future Copaxone generics.

Over the past two decades, Copaxone has been a cash cow for Teva, culminating in annual sales of $4.2 billion in 2013. Since then generic rivals have been available and sales have fallen 64% by last year to $1.5 billion 9including $1 billion in the US) and are expected to fall to $1.2 billion in 2020. Even so this is still a significant amount of revenue.

FDA's biologics list follows legislation enacted by the US Congress protecting biologics drugs. The FDA has published an initial list of 100 drugs to be included on the list as biologics drugs from March 2020, which would require budding generics to pass through the more complex biosimilars track before receiving approval.

Copaxone has not been included in this list but Teva has written to the FDA requesting that it should be. Teva points out that the FDA has previously stated that Copaxone is different from a protein because it has no defined or specific sequence and cites two drugs on the FDA's biologics list that are similar to Copaxone - Bausch + Lomb’s Vitrase and AbbVie’s Creon.

Published by Globes [online], Israel business news - en.globes.co.il - on February 26, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Microsoft campus in Herzliya  credit; Eyal Izhar Microsoft: Exempt Israel from AI-chip export restrictions

Israel is among countries mentioned in a blog post by Microsoft vice chair and president Brad Smith criticizing the restrictions.

Paz gas station credit: Tali Bogdanovsky Gasoline prices in Israel to fall Saturday night

The maximum price of government price controlled 95 octane gasoline at self-service pumps in Israel will fall on Saturday at midnight March 2, 2025, by NIS 0.08 per liter to NIS 7.23 per liter.

Tel Aviv credit: Shutterstock Tel Aviv master plan sees 600,000 residents by 2035

The Tel Aviv District Planning and Building Committee has approved for deposit the TA/5500 master plan for Tel Aviv-Yafo.

Mizrahi Tefahot Bank  credit: Eyal Izhar Mizrahi Tefahot to pay huge dividend on record 2024 profit

The bank reported net profit of NIS 5.5 billion last year, up 11% from NIS 4.9 billion in 2023.

Sheba, Tel Hashomer Hospital Photo: Tamar Matsafi Israel's Sheba climbs in "Newsweek" world hospital top ten

Last year "Newsweek" ranked Sheba Medical Center in ninth place and previously it was in tenth place.

Cyberattack  credit: Shutterstock Israel second most targeted country for cyberattacks

The report by Radware found that Israel suffered 1,550 cyberattacks in 2024, second only to Ukraine which suffered 2,052 attacks.

BIG Fashion Glilot credit: Dror Marmor Israel's biggest mall opens Thursday

BIG Fashion Glilot strip mall is in Ramat Hasharon's new office park, adjacent to Cinema City Glilot.

Tesla Model Y credit: Shutterstock Can Tesla stage a comeback in Israel in 2025?

After taking Israel by storm four years ago, Tesla has gradually lost market shares to Chinese rivals but this trend could change this year.

Ghost jobs illustration: Tali Bogdanovsky 10% of Israeli tech vacancies are ghost jobs

Ethosia CEO Eyal Solomon says the proportion of "ghost" jobs - vacancies that have been advertised but not filled and continue to appear on the company's website - has jumped dramatically in recent years.

Prime Minister Benjamin Netanyahu and Transport Minister Miri Regev credit: Marc Israel Sellem Jerusalem Post Jerusalem Red Line extension awaits ribbon cutting

Opening the light rail extension has been delayed while a date is found for a ceremony attended by Prime Minister Benjamin Netanyahu and Transport Minister Miri Regev.

Tel Aviv light rail Light rail fares in Israel jump 33.3%

Bus fares will also rise 33.3% after the 2025 budget is passed.

Quantum Machines founders credit: Eyal Izhar Israeli co Quantum Machines raises $170m

Sources say that the company's valuation, which before the latest round was $520 million, has now risen to $670 million.

Pay cuts illustration: Shutterstock Treasury plans pay cuts for doctors, teachers, and civil servants

The move is intended to ensure that the budget savings target of NIS 5 billion shekels in 2025 is achieved, as part of efforts to reduce the state budget deficit.

Shekel credit: Shutterstock Vladirina 32 Shekel weakens after BoI rate call

Poria Financial Planning chairman Or Poria: There is growing uncertainty over the collapse of the hostage deal, and the increasing probability of renewed fighting in the south.

Daniel Aronovitz credit: Joseph Laor Insight Partners: $6b and still investing in Israel

Insight Partners newly appointed Israel partner Daniel Aronovitz tells "Globes" about the US firms plans for Israel and reveals the huge extent of past investment.

Bank of Israel Governor Amir Yaron credit: Eyal Izhar, Tali Bogdansky BoI Governor: We hope for two rate cuts in second half

Bank of Israel Governor Prof. Amir Yaron tells "Globes" he remains concerned about inflation, higher demand than supply, and real estate balloon loans.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018